Abstract:BACKGROUND:Ameloblastoma, a common odontogenic tumor located in jaws, generally leads to severe damage to patient's complexion and masticatory function. To expand in jaws, ameloblastoma must have a mechanism of resorbing the surrounding bone. Our objective was to explore the bone-resorption mechanism of ameloblastoma by observing the role of Receptor activator of nuclear factor kappa B ligand (RANKL) and matrix metalloproteinase-9 (MMP-9) in the bone-resorption process.METHODS:In the study, the expression of RANKL and MMP-9 in ameloblastoma was detected using immunohistochemistry (IHC) and RT-PCR. Then, co-culture system of ameloblastoma cells and bone marrow cells from neonatal rabbit was erected to observe the potential of ameloblastoma cells to induce osteoclastogenesis. Finally, the induced osteoclasts were used for in vitro bone-resorption assay. In the co-culture system and the bone-resorption assay, the selective inhibitor of RANKL and MMP-9, osteoprotegerin (OPG) and tissue inhibitor of metalloproteinase-1 (TIMP-1) were, respectively, used for observing the role of RANKL and MMP-9.RESULTS:The expression of RANKL and MMP-9 in ameloblastoma was confirmed. Ameloblastoma cells were found to induce bone marrow cells from neonatal rabbit differentiate into osteoclasts with bone-resorption activity. In addition, OPG was found to, respectively, have markedly inhibitory effect on osteoclastogenesis (P<0.01), and slightly inhibitory action on bone resorption (P<0.05).CONCLUSIONS:Ameloblastoma cells had the potential to induce osteoclastogenesis. Moreover, RANKL played an essential role in the in vitro osteoclast formation and bone resorption induced by ameloblastoma cells.

Expression and significance of receptor activator of nuclear factor kappa B-ligand in ameloblastoma

Role of Receptor Activator of Nuclear Factor Kappa B Lignand in Bone Resorption Caused by Ameloblastoma

The expression of BMP-2 mRNA in ameloblastoma of the jaw bone

The Expression and Significance of RANKL,MMP-9 and MMP-2 in Ameloblastoma

The Role of RANKL and MMP-9 in the Bone Resorption Caused by Ameloblastoma

Role of OPG/RANKL/RANK system during alveolar bone resorption and remodeling

Study on the Mechanism of RANKL in Bone Absorption of Periapical Lesion

Mineralizing Solution and Dexamethasone Enhance Receptor Activator for NF-κB Ligand Expression in Rat Bone Marrow Stromal Cells

Expression and Significance of Receptor Activator of Nuclear Kb Ligand in Odontogenic Keratocyst

The Effect of Alendronate on the Expression of Important Cell Factors in Osteoclasts

Expression of RECK in Ameloblastoma and Its Relationship with Matrix Metalloproteinase-2

Upregulation of Interleukin-8 and Activin A Induces Osteoclastogenesis in Ameloblastoma

Expression of apoptosis-related proteins in ameloblastomas of the jaws

Expression of Osteopontin and Its Receptors in Ameloblastomas.

Proteomics study of bone tissue around ameloblastoma and the potential mechanism of CD36 in bone remodelling

Expression and quantitative analysis of RANKL in normal periodontal tissue of rats

Immunolocalization of Receptor Activator of NF Kappa B Ligand in Rat Periapical Lesions.

Expression and role of metalloproteinase-2 and endogenous tissue regulator in ameloblastoma.

Differential expression of apoptosis-related proteins in various cellular components of ameloblastomas.

Expression of Inducible Nitric Oxide Synthase and Vascular Endothelial Growth Factor in Ameloblastoma

THE EXPRESSION AND SIGNIFICANCE OF MATRIX METALLOPROTEINASE-2(MMP-2) IN AMELOBLASTOMA